Keyword: Turku Bioscience Centre

Treatment outcomes for breast cancer have become better over the years, but proportion of breast cancers still recur even after long periods without signs of cancer remaining dormant in the body. Finnish cancer researchers discovered a mechanism that wakes up these dormant breast cancer cells and demonstrated that preventing the mechanism can significantly improve treatment outcomes in experimental models. 

The research group of Professor Riitta Lahesmaa have discovered a novel modulator for human regulatory T cells. This novel regulator can strengthen or dampen immune response and provides a new basis for therapeutic approaches for immune mediated diseases. The Lahesmaa group is based at Turku Bioscience Centre of the University of Turku and Åbo Akademi University and is part of the InFLAMES Research Flagship.

University of Turku Professors Johanna Ivaska and Lauri Nummenmaa have received significant research funding from the European Research Council ERC. Ivaska received funding for a project that aims to discover how the biological limits of a healthy body influence cancer progression. Nummenmaa’s project examines the link between a person’s negative emotions and their physical well-being.

This year, BioCity Symposium is arranged on-site in Mauno Koivisto Centre, BioCity on 29–30 August 2024, with the title Unleashing the power of metabolism. Registration is open until Friday, 16 August 2024.

BioCity Turku opens a funding call for researchers belonging to BioCity Turku research programs.

In the context of the 33rd BioCity Symposium (29-30 August 2024) the twentieth Elias Tillandz prize will be awarded for the best scientific paper published in 2023 in Turku.

Frontiers of Science seminar program is ready for spring 2024. All seminars are on-site only at 12:00 in BioCity, Presidentti auditorium. Coffee and sandwich are served before each seminar.

A research group from the University of Turku and Turku Bioscience Centre together with Misvik Biology Ltd in Finland have developed a new method for studying how cancer cells function in softer and stiffer tissue environments. This insight challenges the existing paradigm, opening up new possibilities for research in cancer biology and tissue engineering.

Biomedical research often occurs in painfully slow pace. Here, as an alternative approach we aim to pilot rapid research and collaboration. This takes a form of an experimental biomedical workshop / mini-hackathon called “SpeedFish” utilizing rapid zebrafish models for cardiovascular biology and disease.

How can a researcher become an entrepreneur, what does the journey require and why should more researchers aim to commercialise their invention? The Corporate Corner event of the InFLAMES Flagship shares stories of how science can become business, told by interesting speakers and companies. The theme for the next Corporate Corner is The Journey of Turning Science into Business, and it will be held on 6 October in Turku.